Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus clonidine for haloperidol-resistant ICU delirium
NL-OMON38662Phase 4Active, not recruiting
- Sponsor
- Isala
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in delirium comparing Clonidine with Dexmedetomidine (2 arms). Primary endpoint: Duration of alpha2-agonist treatment until delirium resolution. Started Dec 2013; status: active, not recruiting.
02
Drugs
dexmedetomidineclonidine
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON38662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38662.